PCI Biotech Holding ASA: Annual Report 2024

Oslo, Norway, April 24, 2025
The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2024. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2024 is also available on the company’s website www.pcibiotech.com.

For further information, please contact:        
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo                
Ronny Skuggedal, CEO, [email protected], Mobile: +47 940 05 757

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachments

• 2024 Annual report PCI Biotech Holding ASA
• pcibiotechholdingasa-2024-12-31-en

You May Also Be Interested In

• Anmodning om ophør af suspension i enkelte afdelinger under Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select
• WeRide Recognized on Fortune's 2026 Change the World List as the Only Autonomous Driving Company Honored
• Unikie presented the next phase of automated vehicle logistics with Audi